Autor: |
Hélène Carreyre, Grégoire Carré, Maurice Ouedraogo, Clarisse Vandebrouck, Jocelyn Bescond, Claudiu T. Supuran, Sébastien Thibaudeau |
Jazyk: |
angličtina |
Rok vydání: |
2017 |
Předmět: |
|
Zdroj: |
Molecules, Vol 22, Iss 6, p 915 (2017) |
Druh dokumentu: |
article |
ISSN: |
1420-3049 |
DOI: |
10.3390/molecules22060915 |
Popis: |
Dodoneine (Ddn) is one of the active compounds identified from Agelanthus dodoneifolius, which is a medicinal plant used in African pharmacopeia and traditional medicine for the treatment of hypertension. In the context of a scientific program aiming at discovering new hypotensive agents through the original combination of natural product discovery and superacid chemistry diversification, and after evidencing dodoneine’s vasorelaxant effect on rat aorta, superacid modifications allowed us to generate original analogues which showed selective human carbonic anhydrase III (hCA III) and L-type Ca2+ current inhibition. These derivatives can now be considered as new lead compounds for vasorelaxant therapeutics targeting these two proteins. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|